
欧洲人类白细胞抗原 (HLA) 检测市场预测至 2028 年 - 按产品和服务(试剂和消耗品、仪器以及软件和服务)、技术(分子测定技术和非分子测定技术)划分的 COVID-19 影响和区域分析,和最终用户(独立参考实验室、医院和移植中心等)
No. of Pages: 166 | Report Code: BMIRE00025755 | Category: Life Sciences
No. of Pages: 166 | Report Code: BMIRE00025755 | Category: Life Sciences
欧洲人类白细胞抗原(HLA)检测市场预计将从2022年的1.8849亿美元增长到2028年的2.8777亿美元;预计2022年至2028年复合年增长率为7.3%。
HLA的应用范围不断扩大测试使得在多项医疗程序之前必须进行测试。 TriCore Reference Laboratories 的组织相容性实验室为移植、血小板捐献/输血、法医检测、亲子鉴定、疾病关联、药物基因组学和输血医学应用提供 HLA 相关检测;其中,HLA检测常用于疾病关联检测。特定的 HLA 等位基因与各种疾病的高或低暴露程度相关。 HLA 检测还可用作诊断和评估遗传风险的补充方法。确认与每种疾病或药物引起的不良反应相关的 HLA 因子是否存在可以显着影响治疗。此外,输血是需要 HLA 检测的主要程序之一。一些慢性病、外科手术和创伤病例需要输血,以便患者能够生存而不会出现低血液水平的任何副作用。地中海贫血、血癌、镰状细胞性贫血、贫血以及手术和创伤病例等疾病会导致失血,需要输血。因此,慢性病患病率的增加放大了输血的需求,从而推动了HLA检测市场的增长。
随着新的功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动欧洲人类白细胞抗原 (HLA) 检测市场实现显着的复合年增长率。
< h3>
  ;
欧洲人类白细胞抗原(HLA)测试市场分为产品和测试服务、技术、最终用户和国家/地区。基于产品和服务,市场分为试剂和服务耗材、仪器、软件和服务。从技术上来说,欧洲人类白细胞抗原(HLA)检测市场分为分子检测技术和非分子检测技术。分子检测技术细分为基于 PCR 的分子检测、基于测序的分子检测等。根据最终用户,市场分为独立参考实验室、医院和移植中心等。根据国家/地区,欧洲人类白细胞抗原 (HLA) 检测市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。
Thermo FISHER SCIENTIFIC INC.;护理Dx;凯杰;照明公司; Bio-Rad 实验室公司; F. 霍夫曼拉罗什有限公司;宝生物公司; Luminex 公司;奥米克森公司;普罗特兰斯;和 CeGaT GmbH 是欧洲人类白细胞抗原 (HLA) 检测市场的主要公司之一。
Strategic insights for Europe Human Leukocyte Antigen (HLA) Testing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 188.49 Million |
Market Size by 2028 | US$ 287.77 Million |
Global CAGR (2022 - 2028) | 7.3% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品和服务
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Human Leukocyte Antigen (HLA) Testing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Human Leukocyte Antigen (HLA) Testing Market is valued at US$ 188.49 Million in 2022, it is projected to reach US$ 287.77 Million by 2028.
As per our report Europe Human Leukocyte Antigen (HLA) Testing Market, the market size is valued at US$ 188.49 Million in 2022, projecting it to reach US$ 287.77 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.
The Europe Human Leukocyte Antigen (HLA) Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Human Leukocyte Antigen (HLA) Testing Market report:
The Europe Human Leukocyte Antigen (HLA) Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Human Leukocyte Antigen (HLA) Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Human Leukocyte Antigen (HLA) Testing Market value chain can benefit from the information contained in a comprehensive market report.